Cell Mediated Immunity in Older Adults
Completed · Not applicable
Conditions studied: Immunity to Influenza Vaccine
In brief
This study is to study the immune response to the flu vaccine in people 65 years old and older. Only adults 65 years old and older and who are getting their flu vaccine are being asked to join in this study. The investigators plan to enroll approximately 100 people in this study in the 2010-2011 flu season. Vanderbilt is working with the Centers for Disease Control and Prevention on this study. There will be 5 study visits. Up to 4 tablespoons of blood from a vein will be obtained prior to the flu shot. Return visits will be 1, 2, and 4 weeks later,with up to 4 tablespoons of blood drawn again. Patients will be randomized to receive either the standard dose or the high dose flu vaccine. Both flu vaccines are FDA-approved.
Key facts
- Study ID
- NCT01189123
- Run by
- Vanderbilt University
- People needed
- 105
- Starts
- 2010-08-01
- Expected to finish
- 2013-08-01
- Last updated by the study team
- 2014-04-24
Who can join
Age: 65 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- healthy
- aged 65+ years
You may not qualify if…
- <65 years
- influenza vaccine allergy
- Guillain-Barre
- weight <110 pounds
Where it is running
- Vanderbilt University Medical Center — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.